Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with TrkA kinase

References

• Abe, H., Kikuchi, S., Hayakawa, K., Iida, T., Nagahashi, N., Maeda, K., … Laquerre, S. G. (2011). Discovery of a highly potent and selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate). ACS Medicinal Chemistry Letters, 2(4), 320–324. doi:10.1021/ml200004g
   PubMed Web of Science ®Google Scholar
• Bagal, S. K., Omoto, K., Blakemore, D. C., Bungay, P. J., Bilsland, J. G., Clarke, P. J., … Warmus, J. S. (2019). Discovery of allosteric, potent, subtype selective, and peripherally restricted TrkA kinase inhibitors. Journal of Medicinal Chemistry, 62(1), 247–265. doi:10.1021/acs.jmedchem.8b00280
   PubMed Web of Science ®Google Scholar
• Bailey, J. J., Schirrmacher, R., Farrell, K., & Bernard-Gauthier, V. (2017a). Tropomyosin receptor kinase inhibitors: An updated patent review for 2010–2016-Part I. Expert Opinion on Therapeutic Patents, 27(6), 733–751. doi:10.1080/13543776.2017.1297796
   PubMed Web of Science ®Google Scholar
• Bailey, J. J., Schirrmacher, R., Farrell, K., & Bernard-Gauthier, V. (2017b). Tropomyosin receptor kinase inhibitors: An updated patent review for 2010–2016-Part II. Expert Opinion on Therapeutic Patents, 27(7), 831–849. doi:10.1080/13543776.2017.1297797
   PubMed Web of Science ®Google Scholar
• Bayly, C. I., Cieplak, P., Cornell, W., & Kollman, P. A. (1993). A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. The Journal of Physical Chemistry, 97(40), 10269–10280. doi:10.1021/j100142a004
   Web of Science ®Google Scholar
• Bertrand, T., Kothe, M., Liu, J., Dupuy, A., Rak, A., Berne, P. F., … Mathieu, M. (2012). The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition. Journal of Molecular Biology, 423(3), 439–453. doi:10.1016/j.jmb.2012.08.002
   PubMed Web of Science ®Google Scholar
• Case, D., Darden, T., Cheatham, T., III, Simmerling, C., Wang, J., Duke, R., … Kollman, P. (2012). AMBER 12. San Francisco, CA: University of California.
   Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N•log-(N) method for Ewald sums in large systems. Journal of Chemical Physics., 98(12), 10089–10092. doi:10.1063/1.464397
   Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., … Fox, D. J. (2016). Gaussian 09. Wallingford, CT: Gaussian, Inc.
   Google Scholar
• Gotz, A. W., Williamson, M. J., Xu, D., Poole, D., Le Grand, S., & Walker, R. C. (2012). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. Journal of Chemical Theory and Computation, 8(5), 1542–1555. doi:10.1021/ct200909j
   PubMed Web of Science ®Google Scholar
• Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics, 65(3), 712–725. doi:10.1002/prot.21123
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. Journal of Chemical Physics., 79(2), 926–935. doi:10.1063/1.445869
   Web of Science ®Google Scholar
• Norman, B. H., & McDermott, J. S. (2017). Targeting the nerve growth factor (NGF) pathway in drug discovery. Potential applications to new therapies for chronic pain. Journal of Medicinal Chemistry, 60(1), 66–88. doi:10.1021/acs.jmedchem.6b00964
   PubMed Web of Science ®Google Scholar
• Onufriev, A., Bashford, D., & Case, D. A. (2004). Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins: Structure, Function, and Bioinformatics, 55(2), 383–394. doi:10.1002/prot.20033
   PubMed Web of Science ®Google Scholar
• Rocchia, W., Alexov, E., & Honig, B. (2001). Extending the applicability of the nonlinear Poisson − Boltzmann equation: multiple dielectric constants and multivalent ions. The Journal of Physical Chemistry B, 105(28), 6507–6514. doi:10.1021/jp010454y
   Web of Science ®Google Scholar
• Ryckaert, J., Ciccotti, G., & Berendsen, H. (1977). Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics., 23 (3), 327–341. doi:10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Salomon-Ferrer, R., Gotz, A. W., Poole, D., Le Grand, S., & Walker, R. C. (2013). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent Particle Mesh Ewald. Journal of Chemical Theory and Computation, 9(9), 3878–3888. doi:10.1021/ct400314y
   PubMed Web of Science ®Google Scholar
• Skaper, S. D. (2018). Neurotrophic factors: Methods and protocols. New York, NY: Springer.
   Google Scholar
• Wan, S., Yan, R., Jiang, Y., Li, Z., Zhang, J., & Wu, X. (2019). Insight into binding mechanisms of EGFR allosteric inhibitors using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure and Dynamics, 37(16), 4384–4394.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Wan, S., Li, Z., Fu, Y., Wang, G., Zhang, J., & Wu, X. (2018). Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRAF V600E and VEGFR-2 dual inhibitors. European Journal of Medicinal Chemistry, 155, 210–228. doi:10.1016/j.ejmech.2018.05.054
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. doi:10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• Wang, T., Yu, D., & Lamb, M. L. (2009). Trk kinase inhibitors as new treatments for cancer and pain. Expert Opinion on Therapeutic Patents, 19(3), 305–319. doi:10.1517/13543770902721261
   PubMed Web of Science ®Google Scholar
• Wu, P., Clausen, M. H., & Nielsen, T. E. (2015). Allosteric small-molecule kinase inhibitors. Pharmacology & Therapeutics, 156, 59–68. doi:10.1016/j.pharmthera.2015.10.002
   PubMed Web of Science ®Google Scholar
• Wu, X., Fu, Y., Wang, Y., Wan, S., & Zhang, J. (2017). Gaining insight into Crizotinib resistance mechanisms caused by L2026M and G2032R mutations in ROS1 via molecular dynamics simulations and free-energy calculations. Journal of Molecular Modeling, 23(4), 141–146. doi:10.1007/s00894-017-3314-z
   PubMed Web of Science ®Google Scholar
• Wu, X., Wang, Y., Wan, S., & Zhang, J. (2018). Investigation on the binding mechanism of Loratinib with the c-ros oncogene 1 (ROS1) receptor tyrosine kinase via molecular dynamics simulation and binding free energy calculations. Journal of Biomolecular Structure and Dynamics, 36(12), 3106–3113. doi:10.1080/07391102.2017.1378127
   PubMed Web of Science ®Google Scholar
• Yan, W., Lakkaniga, N. R., Carlomagno, F., Santoro, M., McDonald, N. Q., Lv, F., … Li, H. (2019). Insights into current tropomyosin receptor kinase (TRK) inhibitors: Development and clinical application. Journal of Medicinal Chemistry, 62(4), 1731–1760. doi:10.1021/acs.jmedchem.8b01092
   PubMed Web of Science ®Google Scholar